Announcements Trials

Browse Landscape

Phase

Phase NA 8 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma 2 Hematologic Neoplasms 2 Head and Neck Neoplasms 2 Rectal Neoplasms 1 Pain 1 Neoplasms 1 Mucositis 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphedema 1 Glioma 1 Fallopian Tube Neoplasms 1 Carcinoma in Situ 1 Brenner Tumor 1 Breast Neoplasms 1 Anatomic Stage I Breast Cancer AJCC v8 1 Abnormalities, Radiation-Induced 1

Interventions

Fluorouracil 61 Leucovorin 56 Oxaliplatin 51 Capecitabine 42 Irinotecan 29 Bevacizumab 21 Radiotherapy 17 Cetuximab 12 Folfox protocol 11 Chemoradiotherapy 11 Neoadjuvant Therapy 10 Chemotherapy, Adjuvant 9 Surgical Procedures, Operative 6 Drug Therapy 6 XELOX 5 Panitumumab 4 Laparoscopy 4 FOLFOXIRI protocol 4 Transanal Endoscopic Microsurgery 3 Radiation 3 Octreotide 3 IFL protocol 3 Floxuridine 3 Diathermy 3 Celecoxib 3 vatalanib 2 spartalizumab 2 Trinitrotoluene 2 Tegafur 2 Semaxinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Rectal Neoplasms × Methods × Clear all

NCT04288999 2020-06-04

JCOG1801

National Cancer Center Hospital East

Phase 3 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡